Evonik develops a microbial fermentation- based process to produce human collagen

摘要

The specialty chemicals company Evonik has developed a fermentation process for making synthetic collagen with properties similar to those of human collagen but devoid of animal- or human-derived materials. The recombinant technology will, for the first time, provide pharmaceutical, medical, cell culture and tissue engineering markets with a highly soluble, ultra-pure form of collagen that is safe, sustainable and commercially scalable, said the company.